Mar 242020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– CANADA, Toronto – Vasomune Therapeutics, Inc., an early-stage therapeutic biopharmaceutical company developing a novel first-in-class medicine for the treatment of COVID-19/pathogen-induced ARDS, today announced the appointment of Meenu Chhabra to its Board of Directors. Ms. Chhabra is the President and CEO of Proteostasis Therapeutics, Inc. (NASDAQ: PTI). “Ms. Chhabra ...

Vasomune Therapeutics adds Meenu Chhabra to its Board of Directors

Vasomune Therapeutics adds Meenu Chhabra to its Board of Directors

From:: Vasomune Therapeutics adds Meenu Chhabra to its Board of Directors

Sorry, the comment form is closed at this time.